Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Mar ‘25 |
|
|---|---|---|---|---|---|
| $21.3M | $27M | $5.77M | 118% |
|
|
| $21.1M | $102M | $81.3M | 68% |
|
|
| $21.1M | $24.1M | $3.05M | 23.1% |
|
|
154
CRISPR Therapeutics
CRSP
$5.3B
| $20.7M | $96.3M | $75.6M | 62.2% |
|
| $20.7M | $49.4M | $28.7M | 219% |
|
|
| $20.6M | $62.3M | $41.7M | 47.6% |
|
|
| $20.4M | $44.8M | $24.3M | 28.4% |
|
|
| $20.3M | $127M | $106M | 18.8% |
|
|
| $20.3M | $53.4M | $33.1M | 139% |
|
|
| $20.2M | $26.6M | $6.4M | 9.9% |
|
|
161
Vanguard Long-Term Treasury ETF
VGLT
$9.97B
| $20.2M | $24M | $3.79M | 3.98% |
|
| $20M | $35.7M | $15.7M | 52.1% |
|
|
| $19.8M | $20.5M | $628K | 32.9% |
|
|
| $19.7M | $24.5M | $4.83M | 30.1% |
|
|
| $19.6M | $46.7M | $27.1M | 270% |
|
|
| $19.4M | $34.3M | $14.9M | 53.4% |
|
|
| $19.2M | $51.1M | $31.9M | 112% |
|
|
| $19.1M | $24.3M | $5.15M | 15.7% |
|
|
| $19M | $73.9M | $54.9M | 234% |
|
|
| $18.4M | $29.4M | $11M | 39.9% |
|
|
| $18.2M | $36.4M | $18.2M | 37.7% |
|
|
| $18.1M | $29.5M | $11.4M | 128% |
|
|
| $18.1M | $25.2M | $7.13M | 35.9% |
|
|
| $18M | $21.5M | $3.46M | 60.9% |
|
|
| $18M | $23.9M | $5.93M | 34.1% |
|